From acute febrile neutrophilic dermatosis to neutrophilic disease: Forty years of clinical research

被引:141
作者
Wallach, Daniel
Vignon-Pennamen, Marie-Dominique
机构
[1] Hop Tarnier Cochin, Dept Dermatol, F-75006 Paris, France
[2] Hop St Louis, Dept Dermatol, Paris, France
[3] Hop St Louis, Dept Pathol, Paris, France
关键词
D O I
10.1016/j.jaad.2006.07.016
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
In 1964, Sweet described an acute febrile neutrophilic dermatosis. It is now widely accepted that Sweet's syndrome belongs to a group of associated neutrophilic dermatoses. Although clinically dissimilar, Sweet's syndrome, pyoderma gangrenosum, subcorneal pustular dermatosis, erythema elevatum diutinum, and a few other conditions can be considered a part of this same pathologic spectrum of inflammatory disorders because of (1) the existence of transitional and overlap forms; (2) the similar histopathologic feature of an infiltrate by normal polymorphonuclear leukocytes; (3) the possible occurrence of extracutaneous neutrophilic infiltrates, defining the neutrophilic disease; and (4) the frequent association with systemic diseases. According to the localization of the neutrophilic infiltrate, we describe neutrophilic dermatoses en plaques (dermal), superficial (epidermal), and deep (dermal and hypodermal). Almost every organ of the body may be involved by a neutrophilic aseptic inflammation. The main systemic diseases associated with neutrophlic dermatoses are hematologic, gastrointestinal, and rheumatologic diseases. Although the pathophysiology of these conditions is still poorly understood, treatment with systemic anti-inflammatory agents is usually efficacious.
引用
收藏
页码:1066 / 1071
页数:6
相关论文
共 48 条
[1]   Aberrant neutrophil trafficking and metabolic oscillations in severe pyoderma gangrenosum [J].
Adachi, Y ;
Kindzelskii, AL ;
Cookingham, G ;
Shaya, S ;
Moore, EC ;
Todd, RF ;
Petty, HR .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 111 (02) :259-268
[2]   Retropharyngeal and splenic aseptic abscesses treated with prednisone and cyclophosphamide in a patient with ulcerative colitis [J].
André, M ;
Piette, JC ;
Frances, C ;
Wechsler, B ;
Delevaux, I ;
Aumaître, O .
DIGESTIVE DISEASES AND SCIENCES, 2003, 48 (06) :1193-1195
[3]   SIMULTANEOUS OCCURRENCE OF 2 RARE CUTANEOUS MARKERS OF POOR-PROGNOSIS IN MYELODYSPLASTIC-SYNDROME - ERYTHEMA-ELEVATUM-DIUTINUM AND SPECIFIC LESIONS [J].
ARACTINGI, S ;
BACHMEYER, C ;
DOMBRET, H ;
VIGNONPENNAMEN, D ;
DEGOS, L ;
DUBERTRET, L .
BRITISH JOURNAL OF DERMATOLOGY, 1994, 131 (01) :112-117
[4]  
Arbetter KR, 1999, AM J HEMATOL, V61, P126, DOI 10.1002/(SICI)1096-8652(199906)61:2<126::AID-AJH9>3.3.CO
[5]  
2-#
[6]   Sweet's syndrome during treatment with all-trans retinoic acid in a patient with acute promyelocytic leukemia [J].
Arun, B ;
Berberian, B ;
Azumi, N ;
Frankel, SR ;
Luksenburg, H ;
Freter, C .
LEUKEMIA & LYMPHOMA, 1998, 31 (5-6) :613-+
[7]   Sweet's syndrome and malignancy in the UK [J].
Bourke, JF ;
Keohane, S ;
Long, CC ;
Kemmett, D ;
Davies, M ;
Zaki, I ;
GrahamBrown, RAC .
BRITISH JOURNAL OF DERMATOLOGY, 1997, 137 (04) :609-613
[8]   Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial [J].
Brooklyn, TN ;
Dunnill, MGS ;
Shetty, A ;
Bowden, JJ ;
Williams, JDL ;
Griffiths, CEM ;
Forbes, A ;
Greenwood, R ;
Probert, CS .
GUT, 2006, 55 (04) :505-509
[9]   Pyoderma (echthyma) gangrenosum - Clinical and experimental observations in five cases occurring in adults [J].
Brunsting, LA ;
Goeckerman, WH ;
O'Leary, PA .
ARCHIVES OF DERMATOLOGY AND SYPHILOLOGY, 1930, 22 (04) :655-680
[10]   NEUTROPHILIC DERMATOSIS OF MYELOPROLIFERATIVE DISORDERS - ATYPICAL FORMS OF PYODERMA GANGRENOSUM AND SWEETS SYNDROME ASSOCIATED WITH MYELOPROLIFERATIVE DISORDERS [J].
CAUGHMAN, W ;
STERN, R ;
HAYNES, H .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1983, 9 (05) :751-758